HU9501240D0 - Inhibitors of farnesyl-protein transferase - Google Patents

Inhibitors of farnesyl-protein transferase

Info

Publication number
HU9501240D0
HU9501240D0 HU9501240A HU9501240A HU9501240D0 HU 9501240 D0 HU9501240 D0 HU 9501240D0 HU 9501240 A HU9501240 A HU 9501240A HU 9501240 A HU9501240 A HU 9501240A HU 9501240 D0 HU9501240 D0 HU 9501240D0
Authority
HU
Hungary
Prior art keywords
farnesyl
inhibitors
protein transferase
transferase
protein
Prior art date
Application number
HU9501240A
Other languages
English (en)
Other versions
HUT72188A (en
Inventor
S Jane Desolms
Samuel L Graham
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HU9501240D0 publication Critical patent/HU9501240D0/hu
Publication of HUT72188A publication Critical patent/HUT72188A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/02—Thiols having mercapto groups bound to acyclic carbon atoms
    • C07C321/04—Thiols having mercapto groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9501240A 1992-10-29 1993-10-27 Inhibitors of farnesyl-protein transferase HUT72188A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/968,106 US5326773A (en) 1992-10-29 1992-10-29 Inhibitors of farnesyl-protein transferase

Publications (2)

Publication Number Publication Date
HU9501240D0 true HU9501240D0 (en) 1995-06-28
HUT72188A HUT72188A (en) 1996-03-28

Family

ID=25513743

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9501240A HUT72188A (en) 1992-10-29 1993-10-27 Inhibitors of farnesyl-protein transferase

Country Status (14)

Country Link
US (1) US5326773A (hu)
EP (1) EP0668856A4 (hu)
JP (1) JPH08502971A (hu)
KR (1) KR950704247A (hu)
AU (1) AU683627B2 (hu)
CA (1) CA2147286A1 (hu)
CZ (1) CZ107095A3 (hu)
FI (1) FI952010A0 (hu)
HU (1) HUT72188A (hu)
NO (1) NO951647D0 (hu)
NZ (1) NZ257766A (hu)
PL (1) PL308553A1 (hu)
SK (1) SK53995A3 (hu)
WO (1) WO1994010137A1 (hu)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083917A (en) * 1990-04-18 2000-07-04 Board Of Regents, The University Of Texas System Methods and compositions for the identification, characterization and inhibition of farnesyltransferase
US5962243A (en) * 1990-04-18 1999-10-05 Board Of Regents, The University Of Texas System Methods for the identification of farnesyltransferase inhibitors
US8003342B1 (en) 1990-04-18 2011-08-23 Board Of Regents, The University Of Texas System Method for identifying farnesyl transferase inhibitors
US5340828A (en) * 1991-09-30 1994-08-23 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
US5686472A (en) * 1992-10-29 1997-11-11 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5536750A (en) * 1992-10-29 1996-07-16 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5504212A (en) * 1992-10-29 1996-04-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2165176A1 (en) * 1993-06-18 1995-01-05 Samuel L. Graham Inhibitors of farnesyl-protein transferase
US5576293A (en) * 1993-09-30 1996-11-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5439918A (en) 1994-03-14 1995-08-08 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CN1151156A (zh) * 1994-03-15 1997-06-04 卫材株式会社 异戊二烯基转移酶抑制剂
US5436263A (en) * 1994-03-22 1995-07-25 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5420334A (en) * 1994-04-04 1995-05-30 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5523430A (en) * 1994-04-14 1996-06-04 Bristol-Myers Squibb Company Protein farnesyl transferase inhibitors
US5510510A (en) * 1994-05-10 1996-04-23 Bristol-Meyers Squibb Company Inhibitors of farnesyl protein transferase
EP0760813A4 (en) * 1994-05-20 1997-09-03 Merck & Co Inc FARNESYL-PROTEIN TRANSFERASE INHIBITORS
ATE188464T1 (de) * 1994-08-11 2000-01-15 Banyu Pharma Co Ltd Substituierte amidderivate
US5576313A (en) * 1994-08-29 1996-11-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IT1273986B (it) * 1994-09-28 1997-07-14 Merck & Co Inc Inibitori peptidici di farnesil proteina transferasi
US5585359A (en) * 1994-09-29 1996-12-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5571835A (en) * 1994-09-29 1996-11-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5661161A (en) * 1994-09-29 1997-08-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5491164A (en) * 1994-09-29 1996-02-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5523456A (en) * 1994-09-29 1996-06-04 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5652257A (en) * 1994-09-29 1997-07-29 Merck & Co., Inc. Heterocycle-containing inhibitors of farnesyl-protein transferase
US5627202A (en) * 1995-03-29 1997-05-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1996034010A2 (en) * 1995-03-29 1996-10-31 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5534537A (en) * 1995-03-29 1996-07-09 Merck & Co., Inc. Prodrugs of inhibitors of farnesyl-protein transferase
US5624936A (en) * 1995-03-29 1997-04-29 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5578629A (en) * 1995-03-29 1996-11-26 Merck & Co., Inc. Benzamide-containing inhibitors of farnesyl-protein transferase
US5856326A (en) * 1995-03-29 1999-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5631280A (en) * 1995-03-29 1997-05-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5703067A (en) * 1995-05-08 1997-12-30 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
US5756528A (en) * 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5972984A (en) * 1995-06-06 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5663193A (en) * 1995-07-25 1997-09-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5703241A (en) * 1995-10-16 1997-12-30 Merck & Co., Inc. Inhibitor of farnesyl-protein transferase
US6127366A (en) * 1995-11-22 2000-10-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
GB9604311D0 (en) * 1996-02-29 1996-05-01 Merck & Co Inc Inhibitors of farnesyl-protein transferase
WO1997027854A1 (en) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU703203B2 (en) * 1996-01-30 1999-03-18 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5981562A (en) * 1996-01-30 1999-11-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6028201A (en) * 1996-01-30 2000-02-22 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5968965A (en) * 1996-01-30 1999-10-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1998032741A1 (en) * 1997-01-29 1998-07-30 Zeneca Limited Inhibitors of farnesyl protein transferase
DK1025088T3 (da) 1997-10-22 2001-11-12 Astrazeneca Ab Imidazolderivater og deres anvendelse som farnesylproteintransferaseinhibitorer
JP2001520222A (ja) 1997-10-22 2001-10-30 ゼネカ・リミテッド イミダゾール誘導体およびファルネシルタンパク質トランスフェラーゼインヒビターとしてのそれらの使用
US20070148660A1 (en) * 2005-06-16 2007-06-28 The Regents Of The University Of California Treatment of maladaptive substance use with H-ras antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183053B (it) * 1984-02-02 1987-10-05 Farmaceutico Ct Lab Derivati dell'alfa-amino-gamma-butirrolatton e, metodo per prepararli e composizioni farmaceutiche che li contengono
CA2012901A1 (en) * 1989-04-05 1990-10-05 Quirico Branca Amino acid derivatives
US5216013A (en) * 1989-12-04 1993-06-01 G. D. Searle & Co. Aralkyl-N-terminal cycloalkoxy-C terminal amino hydroxy β-amino acid derivatives
US5217991A (en) * 1989-12-04 1993-06-08 G. D. Searle & Co. Cycloalkyl/cycloalkylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
US5141851A (en) * 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
US5043268A (en) * 1990-05-04 1991-08-27 The Trustees Of Princeton University Substrates and inhibitors for prenyl cysteine methyltransferase enzymes
US5185248A (en) * 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
CA2044333A1 (en) * 1990-06-12 1991-12-13 Jackson B. Gibbs Chemotherapeutic agents
US5340828A (en) * 1991-09-30 1994-08-23 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
US5238922A (en) * 1991-09-30 1993-08-24 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
US5686472A (en) * 1992-10-29 1997-11-11 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5504212A (en) * 1992-10-29 1996-04-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase

Also Published As

Publication number Publication date
AU683627B2 (en) 1997-11-20
SK53995A3 (en) 1995-11-08
JPH08502971A (ja) 1996-04-02
HUT72188A (en) 1996-03-28
FI952010A (fi) 1995-04-27
US5326773A (en) 1994-07-05
FI952010A0 (fi) 1995-04-27
NO951647L (no) 1995-04-28
CA2147286A1 (en) 1994-05-11
NZ257766A (en) 1997-04-24
WO1994010137A1 (en) 1994-05-11
PL308553A1 (en) 1995-08-21
KR950704247A (ko) 1995-11-17
EP0668856A1 (en) 1995-08-30
NO951647D0 (no) 1995-04-28
AU5453994A (en) 1994-05-24
CZ107095A3 (en) 1996-10-16
EP0668856A4 (en) 1995-11-22

Similar Documents

Publication Publication Date Title
HU9501240D0 (en) Inhibitors of farnesyl-protein transferase
EP0725650A4 (en) FARNESYL-PROTEIN TRANSFERASE INHIBITORS
EP0755383A4 (en) PROTEIN FARNESYL TRANSFERASE INHIBITORS
EP0833633A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0862435A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0841919A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0817629A4 (en) FARNESYL-PROTEIN TRANSFERASE INHIBITORS
EP0784473A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0777475A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0730467A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0783318A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0891350A4 (en) FARNESYLE PROTEIN TRANSFERASE INHIBITORS
EP1011669A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
GB9604311D0 (en) Inhibitors of farnesyl-protein transferase
EP0891360A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
EP0904080A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0783305A4 (en) FARNESYLE PROTEIN TRANSFERASE INHIBITORS
EP0880320A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0891349A4 (en) FARNESYL-PROTEIN TRANSFERASE INHIBITORS
EP0817630A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0760813A4 (en) FARNESYL-PROTEIN TRANSFERASE INHIBITORS
EP0891352A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
GB9506174D0 (en) Inhibitors of farnesyl-protein transferase
EP0891335A4 (en) FARNESYL-PROTEIN TRANSFERASE INHIBITORS
EP0891353A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee